Webinar – PET imaging to investigate neurodegenerative diseases
|Date & Time||November 27th, 2018|
|Tags||clinical application, Neurodegenerative diseases, PET immaging, Translational Research|
Accurate and prompt diagnosis is vital to accommodate differential prognostic and brain disease management approaches, and to assess the efficacy of experimental therapeutic interventions in clinical trials. PET imaging plays a pivotal role in this regard by providing an in vivo opportunity to visualize the neuroanatomical and functional signatures of these disorders, as well as identifying disease-specific biomarkers of the underlying neurodegenerative processes.
This presentation will provide a brief introduction of the PET modality followed by an overview of the prominent preclinical and clinical application of this well-established and promising imaging tool in neurodegenerative diseases.
Speakers: Sonia Lavisse & Nadja van Camp
Dr. Sonia Lavisse received her PhD in oncology imaging from the Pierre and Marie Curie University in 2006. After completion of this degree she was appointed as a postdoctoral fellow in the Gustave Roussy Institute and was involved in a multimodal project (3D DCE-MRI/ DCE-US/PET) on functional characterization and quantification of tumors. For the past 10 years, Dr Lavisse has been working as a permanent researcher at MIRCen and is in charge of the translational PET imaging research protocols to the clinics, in Parkinson’s and Huntington’s diseases. Her current research interests include functional evaluation of innovative therapeutics namely gene therapy or cell grafts, evaluation and quantification of new tracers for neuroinflammation and better understanding of cognitive and motor features in both neurodegenerative diseases. In particular, Dr. S. Lavisse’s methodological research focusses on the development of analysis techniques to simplify the quantification of neuroinflammation tracers in patients without the requirement of blood. Her research activities take place both at MIRCen and at the Frederic Joliot Hospital (SHFJ) in Orsay in collaboration with neurologists and nuclear imaging physicians. In 2018, Dr S. Lavisse received an inter-university degree in anatomical and functional CNS imaging from the Pitie Salpetriere Medical University.
Dr. Nadja Van Camp obtained her PhD in Biomedical Sciences at the University Of Antwerp (Belgium) in 2005. After her initial MRI research on the rodent brain, she was introduced into PET imaging during her Post-Doc at the CEA (CEA-SHFJ, France) in collaboration with the University Of Antwerp (Belgium). During this 4-year research period, she contributed to the validation of new TSPO-ligands and new animal models of neurodegenerative diseases. Since 2009, she joined MIRCen, where is in charge of the preclinical PET Imaging Platform focusing on the validation of new radioligands, animal models and the validation of therapeutical strategies by PET imaging.
Please register here for this webinar on November 27, 2018 2:00 PM CET at:
After registering, you will receive a confirmation email containing information about joining the webinar.
This webinar is part of a series of 4 neuroimaging webinars jointly powered by EATRIS and NEURATRIS, covering the usage of CEST-MRI, optical imaging, PET and Ultrahigh Field MRI in neurodegenerative diseases and their potential application in translational medicine. For more information, please visit: https://eatris.eu/insights/neuroimaging-webinar-series-in-november/